Dr. Patrick Vallance, president of
pharmaceuticals R&D;, leads reforms through
all stages of drug development. p. 24
Creating
Start-Up Style
Innovation
at GSK
Connect. Collaborate. Contribute.
NOVEMBER 2014
PLUS LEADERS INSIGHTS INSIGHTS
How to Build Real
Patient-Centered
Pharma Companies 30
Executive team at PatientsLikeMe
discuss why biopharm companies
struggle to engage with patients.
Cannabis-Based
Pharmaceuticals:
The Next Frontier? 46
How can this new pharma market
develop using conventional FDA
regulatory approval pathways?
Cancer Immunotherapy —
Companies At Stake 36
Fates depend on competing
and cooperating with the other
contenders.
A Republican Senate
vs. Obamacare 10
Companies to Watch 14
Outsourcing Insights 16